42 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should … be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should … be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
to conflicts of interest.
3. Compensation and Benefits.
Salary. As of May 1, 2024, Executive’s annual salary (the “Salary”) shall be $410,000, less … the Executive remains employed through the date of payment.
Benefits. Executive shall participate in benefits offered to the Company’s other executives
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits … associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits
10-Q
2024 Q1
EX-10.1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
.
This letter agreement (this “Letter Agreement”) confirms our recent discussions about, among other matters, certain compensation and benefits matters
424B3
ezycfp1c0 ww
16 Apr 24
Prospectus supplement
5:49pm
424B3
1l9adbr
16 Apr 24
Prospectus supplement
5:45pm
10-K
EX-97.1
in9oz9wboi8vkq4w
16 Apr 24
Annual report
4:48pm
10-K
EX-4.2
r678nzdw
16 Apr 24
Annual report
4:48pm
10-K
4iluteau
16 Apr 24
Annual report
4:48pm
S-8
EX-4.5
yich5w3r6q
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-4.6
6dlkn5rru975c
12 Apr 24
Registration of securities for employees
7:22pm
8-K
EX-1.1
78xo0npu 980hd
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
lkm5yl5wm4ekpcgvf
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
uulc4
20 Feb 24
Prospectus supplement with pricing info
5:28pm